GE Healthcare Launches Customized Training Courses for Improving Customers’ Biopharmaceutical Processes
News Jun 24, 2008
GE Healthcare has announced the launch of customized training courses for improving biopharmaceutical processes. The new courses are an extension of GE Healthcare’s Fast Trak™ Training and Education programme offering.
The new courses can now be tailored to match specific training needs, and may be held on-site at the customer’s facilities to reduce travel costs and extend the training opportunity to all relevant employees in one session.
Fast Trak sessions are typically run over 2-5 days and provide insight into many important aspects of biopharmaceutical processes. Customers can discuss their specific training needs with GE Healthcare bioprocess experts and select from a wide variety of topics including downstream processing, technology transfer, column packing, chromatography, filtration, process optimization and scale-up. The courses are objective, not commercially oriented, and integrate theory and practice with a high ratio of instructors and instruments to trainees.
Darcy Birse, Global Head, Training & Education at GE Healthcare, commented: “Travel time and costs can be sometimes be an issue for our customers when considering training and education courses. Our extended offering aims to help our customers to overcome these drawbacks, while ensuring that the course content is tailored exactly to employee needs.”
The Fast Trak Training and Education offering from GE Healthcare is now in its 20th year and provides a learning experience for process development and manufacturing scientists, staff scientists and engineers, plant operators and support staff.
Bicycle Therapeutics Expands Strategic Partnership with AstraZenecaNews
New programs added in respiratory and cardio-metabolic diseases.READ MORE
Worldwide Clinical Trials Receives 2018 CRO Leadership AwardsNews
Life Science Leader and Industry Standard Research assess 70 contract research organizations, honoring Worldwide Clinical Trials for fifth consecutive year.READ MORE
WuXi Biologics to Invest in Biologics Manufacturing Facility in SingaporeNews
WuXi Biologics' first overseas site in Asia.READ MORE
Comments | 0 ADD COMMENT
2nd Annual Artificial Intelligence in Drug Development Congress
Sep 20 - Sep 21, 2018